Hlx Life Sciences Tech Stack
Life sciences talent consultancy for pharma, biotech, and medical-device companies
Hlx Life Sciences is a talent consultancy founded in 2024 with offices in Basel and London, focused on staffing shortages across pharma, biotech, TechBio, CROs, CDMOs, health tech, and medical devices. The tech stack reveals deep domain expertise: sequencing platforms (Illumina, PacBio, Oxford Nanopore), clinical-trial infrastructure (HL7, PACS, Medidata, CDISC), ML frameworks (PyTorch, TensorFlow, Flyte, Nextflow), and cloud compute (AWS, GCP, Azure, Kubernetes). Active projects span clinical trials (COPD, pediatric gene therapy, rare epilepsy) and cell-therapy programs, while hiring is research-heavy (8 roles) with senior and director-level positions, indicating they're building expertise to advise clients on complex asset pipelines.
Tech Stack 40 technologies
What Hlx Life Sciences Is Building
◆Challenges
- Compliance with pv regulations
- Accelerating therapeutic discovery across complex diseases
- Inspections and audits
- Standardising neurocognitive assessments across sites
- Ensuring consistent endpoint evaluation
- Late stage assets moving towards fda approval
- Managing cro vendor performance
- Safety reporting
- Speed to first 360
- Embedding systems and processes
▲Active Projects
- Ncfb study
- Pediatric gene therapy programme
- Insight-driven account plans
- Copd study
- Accelerator training programme
- High-throughput sequencing sample processing pipelines
- Rare pediatric epilepsy study
- Engineered-cell therapy programmes
- Platform expansion into additional therapeutic indications
- Phase ii–iii clinical trials
Hiring Activity
Department
Seniority
Notable leadership hires: Clinical Program Director
